Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study (Q39693553)
Jump to navigation
Jump to search
scientific article published on 25 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study |
scientific article published on 25 October 2011 |
Statements
1 reference
Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study (English)
1 reference
Richard S Finn
1 reference
Carmelo Bengala
1 reference
Nuhad Ibrahim
1 reference
Henri Roché
1 reference
Joseph Sparano
1 reference
Lewis C Strauss
1 reference
Justin Fairchild
1 reference
Oumar Sy
1 reference
Lori J Goldstein
1 reference
25 October 2011
1 reference
1 reference
17
1 reference
21
1 reference
6905-6913
1 reference
Identifiers
1 reference
1 reference